David Sinclaire Van Mater

David Sinclaire Van Mater

Associate Professor of Pediatrics

Overview

I am a pediatric oncologist with a specific interest in hereditary cancer syndromes and sarcoma. I am also director of the Duke Comprehensive Neurofibromatosis Clinic where I see children and adults with neurofibromatosis type I and II, in addition to schwannomatosis.

Positions

Associate Professor of Pediatrics in the School of Medicine

2024 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2018 School of Medicine

Education

MD./PhD., University of Michigan, Ann Arbor 2006

2006 University of Michigan, Ann Arbor

Pediatrics Internship and Residency, University of Michigan, Ann Arbor, PEDIATRICS 2006 - 2009

2009 University of Michigan, Ann Arbor

Pediatric Hematology/Oncology Fellowship, Duke University, School of Medicine, PEDIATRICS 2009 - 2013

2013 Duke University, School of Medicine

Publications, Grants & Awards

Grants (10)
Academics Articles (31)
Conference Pages (1)

Showing 1 - 5 of 10

Genome Editing for the Treatment of Neurofibromatosis Type I

2022-2026Gilbert Family Foundation

Phase I study of PD-0332991 for pediatric patiens with retinoblastoma protein (RB)-positive recurrent or refractory central nervous system (CNS) tumors.

2014-2026Pfizer, Inc.

MAIN STUDY: Developing Evidence-Based Crieteria for Initiating Treatment fo NF1-OPG.

2015-2025Children's Tumor Foundation

Exploring the Use of Gene Therapies to Treat Neurofibromatosis Type I

2022-2024National Institutes of Health

A phase 2b trial of the MEK 1/2 inhibitor (MEKi) PD-0325901 in adult and pediatric patient with neurofibromatosis type 1 (NF1)-associated inoperable plexiform neurofibromas (PNs) that are causing significant morbidity

2020-2023SpringWorks Therapeutics

DCI Centers, Cancer Types & Labs

Duke Sarcoma Center

Pediatric Cancers

Offices & Contact

Dept of Pediatrics
Durham, NC
27710

102382
Durham, NC
27710